Article Cited by others


Targeted therapies in development for non-small cell lung cancer

Reungwetwattana Thanyanan, Dy Grace Kho

Year : 2013| Volume: 12| Issue : 1 | Page no: 22-22

   This article has been cited by
1 Knockdown of PSF1 expression inhibits cell proliferation in lung cancer cells in vitro
Jingyao Zhang,Qifei Wu,Zhe Wang,Yong Zhang,Guangjian Zhang,Junke Fu,Chang Liu
Tumor Biology. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 Real-World Treatment Patterns and Costs in a US Medicare Population with Metastatic Squamous Non–Small Cell Lung Cancer
Keith L. Davis,Ravi K. Goyal,Stephen L. Able,Jacqueline Brown,Li Li,James A. Kaye
Lung Cancer. 2014;
[Pubmed]  [Google Scholar] [DOI]
3 Anti-Proliferative Effects of Evodiamine in Human Lung Cancer Cells
Ji-Young Hong,So Hyun Park,Hye-Young Min,Hyen Joo Park,Sang Kook Lee
Journal of Cancer Prevention. 2014; 19(1): 7
[Pubmed]  [Google Scholar] [DOI]
4 Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy
Giuseppe Bronte,Francesca Lo Vullo,Gianfranco Pernice,Antonio Galvano,Eugenio Fiorentino,Giuseppe Cicero,Viviana Bazan,Christian Rolfo,Antonio Russo
Expert Opinion on Investigational Drugs. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo
C L Schwab,S Bellone,D P English,D M Roque,S Lopez,E Cocco,R Nicoletti,I Bortolomai,E Bonazzoli,E Ratner,D-A Silasi,M Azodi,P E Schwartz,T J Rutherford,A D Santin
British Journal of Cancer. 2014;
[Pubmed]  [Google Scholar] [DOI]
6 From mice to men: GEMMs as trial patients for new NSCLC therapies
Sarah A. Hayes,Amanda L. Hudson,Stephen J. Clarke,Mark P. Molloy,Viive M. Howell
Seminars in Cell & Developmental Biology. 2014; 27: 118
[Pubmed]  [Google Scholar] [DOI]


Read this article